Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prophylactic continuous vs on-demand ibuprofen for primary dysmenorrhea (randomized crossover)
ChiCTR2600122558Phase 4Recruiting
- Sponsor
- Peking University
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ibuprofen in primary dysmenorrhea (PD) (3 arms), sponsored by Peking University. Primary endpoint: Difference in VAS peak score within 3 days before menstruation. Started Apr 2026; status: recruiting.
02
Drugs
ibuprofen
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on ChiCTR2600122558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600122558.